Thiopentone inhibits endothelium-dependent relaxations of rat aortas regulated by endothelial Ca2+-dependent K+ channels

European Journal of Pharmacology

Volumn 371, Issue 2-3, 1999, Pages 179-185

  Ishida, Kazuyoshi ^a   Kinoshita, Hiroyuki ^a   Kobayashi, Sei ^a   Sakabe, Takefumi ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acetylcholine; Aorta; Endothelium dependent relaxation; Iberiotoxin; K+ channel, Ca2+ dependent; Thiopentone

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ACETYLCHOLINE; APAMIN; BARBITURIC ACID DERIVATIVE; CALCIUM; IBERIOTOXIN; N(G) NITROARGININE METHYL ESTER; NITROPRUSSIDE SODIUM; PAPAVERINE; PHENOBARBITAL; PHENYLEPHRINE; POTASSIUM CHANNEL; THIOPENTAL;

ANIMAL TISSUE; AORTA; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; CALCIUM; DRUG INTERACTIONS; HYPNOTICS AND SEDATIVES; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENOBARBITAL; POTASSIUM CHANNELS; RATS; RATS, INBRED WKY; THIOPENTAL;

EID: 0032911844     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00177-6     Document Type: Article

References (35)

1. K) potassium currents in myocardium: implications for the mechanism of action. Anesth. Analg. 76:1993;18-23.
2. Bolotina V.M., Najibi S., Palacino J.J., Pagano P.J., Cohen R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 368:1994;850-853.
3. Burch P.G., Stanski D.R. The role of metabolism and protein binding in thiopental anesthesia. Anesthesiology. 58:1983;146-152.
4. Carnes C.A., Muir W.W., Van Wagoner D.R. Effect of intravenous anesthetics on inward rectifier potassium current in rat and human ventricular myocytes. Anesthesiology. 87:1997;327-334.
5. Champion H.C., Kadowitz P.J. Vasodilator responses to acetylcholine, bradykinin, and substance P are mediated by a TEA-sensitive mechanism. Am. J. Physiol. 273:1997;R414-R422.
6. Cohen R.A., Plane F., Najibi S., Huk I., Malinski T., Garland C.J. Nitric oxide is the mediator of both endothelium-dependent relaxation and hyperpolarization of the rabbit carotid artery. Proc. Natl. Acad. Sci. USA. 94:1997;4193-4198.
7. + channels contribute to vascular tone. Am. J. Physiol. 267:1994;H1135-H1141.
8. Galvez A., Gimenez-Gallego G., Reuben J.P., Roy-Contancin L., Feigenbaum P., Kaczorowski G.J., Garcia M.L. Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion buthus tamulus. J. Biol. Chem. 265:1990;11083-11090.
9. Garthwaite J., Southam E., Boulton C.L., Nielsen E.B., Schmidt K., Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48:1995;184-188.
10. + channel contributes to bradykinin-induced stimulation of nitric oxide synthesis in pig aortic endothelial cells. Biochim. Biophys. Acta. 1137:1992;162-170.
11. sK) expressed in Xenopus oocytes. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;404-409.
12. Johns R.A. Endothelium, anesthetics, and vascular control. Anesthesiology. 79:1993;1381-1391.
13. Kessler P., Lischke V., Hecker M. Etomidate and thiopental inhibit the release of endothelium-derived hyperpolarizing factor in the human renal artery. Anesthesiology. 84:1996;1485-1488.
14. Kim B.H., Fulco A.J. Induction of barbiturates of a cytochrome P-450-dependent fatty acid monooxygenase in Bacillus megaterium: relationship between barbiturate structure and inducer activity. Biochem. Biophys. Res. Commun. 116:1983;843-850.
15. Kinoshita H., Katusic Z.S. Nitric oxide and effects of cationic polypeptides in canine cerebral arteries. J. Cereb. Blood Flow Metab. 17:1997;470-480.
16. Kinoshita H., Ishida K., Ishikawa T. Thiopentone and propofol impair relaxation produced by ATP-sensitive potassium channel openers in the rat aorta. Br. J. Anaesth. 81:1998;766-770.
17. + channels. Am. J. Physiol. 271:1996;H1498-H1506.
18. Kuriyama H., Kitamura K., Nabata H. Pharmacological and physiological significance of ion channels and factors that modulate them in vascular tissues. Pharmacological Rev. 47:1995;387-573.
19. Latorre R., Oberhauser A., Labarca P., Alvarez O. Varieties of calcium-activated potassium channels. Ann. Rev. Physiol. 51:1989;385-399.
20. Lischke V., Busse R., Hecker M. Selective inhibition of barbiturates of the synthesis of endothelium-derived hyperpolarizing factor in the rabbit carotid artery. Br. J. Pharmacol. 115:1995;969-974.
21. Luckhoff A., Busse R. Calcium influx into endothelial cells and formation of endothelium-derived relaxing factor is controlled by the membrane potential. Pflügers Arch. 416:1990;305-311.
22. Magyar J., Szabo G. Effects of volatile anesthetics on the G protein-regulated muscarinic potassium channel. Mol. Pharmacol. 50:1996;1520-1528.
23. Marchenko S.M., Sage S.O. Calcium-activated potassium channels in the endothelium of intact rat aorta. J. Physiol. 492:1996;53-60.
24. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
25. G-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br. J. Pharmacol. 99:1990;408-412.
26. Morgan D.J., Blackman G.L., Paull J.D., Wolf L.J. Pharmacokinetics and plasma binding of thiopental: I. Studies in surgical patients. Anesthesiology. 54:1981;468-473.
27. Moro M.A., Russell R.J., Cellek S., Lizasoain I., Su Y., Darley-Usmar V.M., Radomski M.W., Moncada S. cGMP mediates the vascular and platelet actions of nitric oxide: Confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad. Sci. USA. 93:1996;1480-1485.
28. + current and hyperpolarization in human endothelial cells. Biochem. Biophys. Res. Commun. 236:1997;340-343.
29. Nelson M.T., Quayle J.M. Physiological roles and properties of potassium channels in arterial smooth muscle. Am. J. Physiol. 268:1995;C799-C822.
30. Olson L.J., Knych E.T. Jr., Herzig T.C., Drewett J.G. Selective guanylyl cyclase inhibitor reverses nitric oxide-induced vasorelaxation. Hypertension. 29:1997;254-261.
31. Piatt J.H. Jr., Schiff S.J. High dose barbiturate therapy in neurosurgery and intensive care. Neurosurgery. 15:1984;427-444.
32. Pollock J.S., Forstermann U., Mitchell J.A., Warner T.D., Schmidt H.H.H.W., Nakane M., Murad F. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA. 88:1991;10480-10484.
33. Sakai F., Hiraoka M., Amaha K. Comparative actions of propofol and thiopentone on cell membranes of isolated guineapig ventricular myocytes. Br. J. Anaesth. 77:1996;508-516.
34. Terasako K., Nakamura K., Toda H., Kakuyama M., Hatano Y., Mori K. Barbiturates inhibit endothelium-dependent and independent relaxations mediated by cyclic GMP. Anesth. Analg. 78:1994;823-830.
35. + channel in cultured vascular endothelial cells. Pflügers Arch. 422:1992;66-74.